Discovery of quinolines as selective glucocorticoid receptor agonists.

Bioorg Med Chem Lett

Medicinal Chemistry Berlin, Lead Generation & Optimization, Bayer Schering Pharma AG, Berlin D-13342, Germany.

Published: October 2010

The dissociated glucocorticoid receptor (GR) agonist ZK 216348 is rendered GR-selective over other nuclear hormone receptors through replacing the methylbenzoxazine with a quinoline moiety. Compounds were shown to be efficacious in cell assays with respect to inflammation endpoints, along with reduced activity in a transactivation assay, hinting at an improved therapeutic window over corticosteroids.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2010.07.125DOI Listing

Publication Analysis

Top Keywords

glucocorticoid receptor
8
discovery quinolines
4
quinolines selective
4
selective glucocorticoid
4
receptor agonists
4
agonists dissociated
4
dissociated glucocorticoid
4
receptor agonist
4
agonist 216348
4
216348 rendered
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!